Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity

Behavioural Brain Research

Volumn 81, Issue 1-2, 1996, Pages 123-133

  Weiner, I ^a   Gal, G ^a   Rawlins, J N P ^b   Feldon, J ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Institute of Toxicology Schwerzenbach   (Switzerland)

Author keywords

activity; core; latent inhibition; nucleus accumbens; rat; shell

Indexed keywords

AMPHETAMINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOPAMINERGIC SYSTEM; LATENT INHIBITION; MALE; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

AMPHETAMINE; ANIMALS; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRINKING; EMOTIONS; HALOPERIDOL; HANDLING (PSYCHOLOGY); MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; STIMULATION, CHEMICAL;

EID: 0030297527     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(96)00051-4     Document Type: Article

References (80)

1. [1] Ackil, J., Mellgren, R.L., Halgren, C. and Frommer S.P., Effects of CS preexposure on avoidance learning in rats with hippocampal lesions, J. Comp. Physiol. Psychol., 69 (1969) 739-747.
2. [2] Anscombe, F., The disorder of consciousness in schizophrenia, Schiz. Bull., 13 (1987) 241-260.
3. [3] Aylward, R.L.M., Bolam, J.P. and Totterdell, S., The nucleus accumbens as a site of interaction between limbic somatostatin and cholecystokinin, and mesolimbic dopamine, Behav. Pharmacol., (1989) S1.204.
4. [4] Aylward, R.L.M. and Totterdell, S., Neurons in the ventral subiculum, amygdala and entorhinal cortex which project to the nucleus accumbens: their input from somatostatin-immunoreactive boutons, J. Chem. Neuroanat., 6 (1993) 31-42.
5. [5] Baruch, I., Hemsley, D. and Gray, J.A., Differential performance of acute and chronic schizophrenics in a latent inhibition task, J. Nerv. Ment. Dis., 176 (1988) 598-606.
6. [6] Bogerts, B., Meertz, E. and Schonfeld-Bausch, R., Basal ganglia and limbic system pathology in schizophrenia, Arch. Gen. Psychiatry, 42 (1985) 784-791.
7. [7] Christison, G.W., Atwater, G.E., Dunn, L.A. and Kilts, C.D., Haloperidol enhancement of latent inhibition: relation to therapeutic action?, Biol. Psychiatry, 23 (1988) 746-749.
8. [8] Creese, I. and Iversen, S.D., The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res., 83 (1975) 419-436.
9. [9] Deutch, A.Y. and Cameron, D.S., Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell, Neuroscience, 46 (1992) 49-56.
10. [10] Di Chiara, G., On the preferential release of mesolimbic dopamine by amphetamine, Neuropsychopharmacology, 5 (1991) 243-244.
11. [11] Dunn, L.A., Atwater, G.E. and Kilts, C.D., Effects of antipsychotic drugs on latent inhibition - sensitivity and specificity of an animal behavioral model of clinical drug action, Psychopharmacology, 112 (1993) 315-323.
12. [12] Feldon, J. and Weiner, I., Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system, Psychopharmacology, 95 (1988) 231-236.
13. [13] Feldon, J. and Weiner, I., The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli, Biol. Psychiatry, 29 (1991) 635-646.
14. [14] Gray, J.A., Feldon, J., Rawlins, J.N.P., Hemsley, D.R. and Smith, A.D., The neuropsychology of schizophrenia, Behav. Brain Sci., 14 (1991) 1-84.
15. [15] Gray, J.A., Joseph, M.H., Hemsley, D.R., Young, A., M.H., Warburton, E.C., Boulenguez, P., Grigoryan, G.A., Peters, S.L., Rawlins, J.N.P., Tai, C.T., Yee, B.K., Cassaday, H., Weiner, I., Gal, G., Gusak, O., Joel, D., Shadach, E., Shalev, U., Tarrasch, R. and Feldon, J., The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia, Behav. Brain Res., in press.
16. [16] Gray, N.S., Hemsley, D.R. and Gray, J.A., Abolition of latent inhibition in acute, but not chronic, schizophrenics, Neurol. Psychiat. Brain Res., 1 (1992) 83-89.
17. [17] Gray, N.S., Pickering, A.D., Hemsley, D.R., Dawling, S. and Gray, J.A., Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in Man. Psychopharmacology, 107 (1992b) 425-430.
18. [18] Groenewegen, H.J., Berendse, H.W., Meredith, G.E., Haber, S.N., Voorn, P., Wolters, J.G. and Lohman, A.H.M., Functional anatomy of the ventral, limbic system-innervated striatum. In: P. Willner and J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action, John Wiley, Chichester, 1991, pp. 19-60.
19. [19] Groenewegen, H.J., Vermeulen-Van der Zee, E., te Kortschot, A. and Witter, M.P., Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin, Neuroscience, 23 (1987) 103-120.
20. [20] Hall, G., Perceptual and Associative Learning, Oxford University Press, New York, 1991.
21. [21] Hernandez, L. and Hoebel, B.G., Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis, Life Sci., 42 (1988) 1705-1712.
22. [22] Johnson, L.R., Aylward, R.L.M., Hussain, Z. and Totterdell, S., Input from the amygdala to the rat nucleus accumbens: its relationship with tyrosine hydroxylase immunoreactivity and identified neurons, Neuroscience, 61 (1994) 851-865.
23. [23] Kaye, H. and Pearce, J.M., Hippocampal lesions attenuate latent inhibition and the decline of the orienting response in rats, Q. J. Exp. Psychol., 39B (1987) 107-125.
24. [24] Kaye, H. and Pearce, J.M., Hippocampal lesions attenuate latent inhibition of a CS and of a neutral stimulus, Psychobiology, 15 (1987) 293-299.
25. [25] Kelley, A.E., Domesick, V.B. and Nauta, W.J.H., The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods, Neuroscience, 1 (1982) 615-630.
26. [26] Kelley, A.E. and Domesick, V.B., The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat. An anterograde-and retrograde-horseradish peroxidase study, Neuroscience, 1 (1982) 2321-2335.
27. [27] Kelly, P.H. and Roberts, D.C.S., Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi, Pharmacol. Biochem. Behav., 19 (1983) 137-143.
28. [28] Kelly, P.H., Seviour, P.W. and Iversen, S.D., Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res., 94 (1975) 507-522.
29. [29] Killcross, A.S., Dickinson, A. and Robbins, T.W., Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction, Psychopharmacology, 115 (1994) 185-195.
30. [30] Killcross, A.S., Dickinson, A. and Robbins, T.W., Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively - and appetitively - motivated paradigms: evidence for dopamine-reinforcer interactions, Psychopharmacology, 115 (1994) 196-205.
31. [31] Killcross, A.S. and Robbins, T.W., Differential effects of intraaccumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm, Psychopharmacology, 110 (1993) 479-489.
32. [32] Kita, H. and Kitai, S.T., Amygdaloid projections to the frontal cortex and the striatum in the rat, J. Comp. Neurol., 298 (1990) 40-49.
33. [33] Krettek, J.F. and Price, J.L., Amygdaloid projections to subcortical structures within the forebrain and brain stem in the rat and cat, J. Comp. Neurol., 178 (1978) 225-254.
34. [34] Kuczenski, R. and Segal, D., Concomitanat characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis, J. Neurosci., 9 (1989) 2051-2065.
35. [35] Liddle, P.F., Friston, K.J., Frith, C.D., Jones, T., Hirsh, S.R. and Frackowiak, R.S.J., Patterns of cerebral blood flow in schizophrenia, Br. J. Psychiatry, 160 (1992) 179-186.
36. [36] Lubow, R.E., Latent inhibition, Psychol. Bull., 79 (1973) 398-407.
37. [37] Lubow, R.E., Latent Inhibition and Conditioned Attention Theory, Cambridge University Press, Cambridge, UK, 1989.
38. [38] Lubow, R.E. and Gewirtz, J.C., Latent inhibition in humans: data, theory, and implications for schizophrenia, Psychol. Bull., 117 (1995) 87-103.
39. [39] Lubow, R.E., Weiner, I. and Schnur, P., Conditioned attention theory. In: G.H. Bower (Ed.), The Psychology of Learning and Motivation, Vol. 15, Academic Press, New York, 1981, pp. 1-49.
40. [40] Mackintosh, N.J., A theory of attention: variations in the associability of stimuli with reinforcement, Psychol. Rev., 82 (1975) 276-298.
41. [41] Mackintosh, N.J., Conditioning and Associative Learning, Oxford University Press, New York, 1983.
42. [42] Makanjuola, R.O.A. and Ashcroft, G.W., Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei, Psychopharmacology, 76 (1982) 333-340.
43. [43] Maldonado-Irizarry, C.S. and Kelley, A.E., Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions, Psychopharmacology, 116 (1994) 65-72.
44. [44] McDonald, A.J., Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain, Neuroscience, 44 (1991) 15-33.
45. [45] Moore, J.W. and Stickney, K.J., Formation of attentional-associative networks in real time: role of the hippocampus and implications for conditioning, Physiol. Psychol., 8 (1980) 207-217.
46. [46] Nuechterlein, K.H. and Dawson, M.E., Information processing and attentional functioning in the developmental course of the schizophrenic disorder, Schiz. Bull., 10 (1984) 160-203.
47. [47] Oades, R.D., The role of noradrenaline in tuning and dopamine in switching between signals in the CNS, Neurosci. Biobehav. Rev., 9 (1985) 261-282.
48. [48] Paxinos, G. and Watson, C, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, 1986.
49. [49] Philipson, O.T. and Griffiths. A.C., The topographic order of inputs to the nucleus accumbens in the rat, Neuroscience, 16 (1985) 2775-296.
50. [50] Pijnenburg, A.J.J., Honig, W.M.M. and van Rossum, J.M., Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat, Psychopharmacology, 41 (1975) 87-95.
51. [51] Raisman, G., Cowan, W.M. and Powell, T.P.S., An experimental analysis of the different projection of the hippocampus, Brain, 89 (1966) 83-108.
52. [52] Robbins, T.W. and Everitt, B.J., Functional studies of the central catecholamines, Int. Rev. Neurobiol., 23 (1982) 303-365.
53. [53] Sharp, T., Zetterström, T., Ljungberg, T. and Ungerstedt, U., A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis, Brain Res., 401 (1987) 322-330.
54. [54] Solomon, P., Lohr, C. and Moore, J.W., Latent inhibition of the rabbit's nictitating response: summation tests for active inhibition as a function of number of CS preexposures, Bull. Psychon. Soc., 4 (1974) 557-559.
55. [55] Solomon, P.R., Crider, A., Winkelman, J.W., Turi, A., Kamer, R.M. and Kaplan, L.J., Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder, Biol. Psychiatry, 16 (1981) 519-537.
56. [56] Solomon, P.R. and Staton, D.M., Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus, Biol. Psychiatry, 17 (1982) 743-756.
57. [57] Staton, D.M. and Solomon, P., Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat, Physiol. Psychol., 12 (1984) 159-162.
58. [58] Stevens, J.R., An anatomy of schizophrenia, Arch. Gen. Psychiat., 29 (1973) 177-189.
59. [59] Stevens, J.R., Neuropathology of schizophrenia, Arch. Gen. Psychiatry, 39 (1982) 1131-1139.
60. [60] Swerdlow, N.R. and Koob, G.F., Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function, Behav. Brain Res., 10 (1987) 215-217.
61. [61] Tai, C.T., Cassaday, H.J., Feldon, J. and Rawlins, J.N.P., Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats, Neurobiol. Learn. Memory, 64 (1995) 36-48.
62. [62] Van den Bos, R. and Cools, A.R., The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviors, Life Sci., 44 (1989) 1697-1704.
63. [63] Voorn, P., Gerfen, C.R. and Groenwegen, H.J., Compartmental organization of the ventral striatum of the rat: immunohistochemichal distribution of enkephalin, substance P, dopamine and calcium-binding protein, J. Comp. Neurol., 251 (1989) 84-99.
64. [64] Warburton, E.C., Joseph, M.H., Feldon, J., Weiner, I. and Gray, J.A., Antagonism of amphetamine-induced disruption of LI in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron, Psychopharmacology, 114 (1994) 657-664.
65. [65] Weinberger, D.R., Implications of normal brain development for the pathogenesis of schizophrenia, Arch. Gen. Psychiatry, 44 (1987) 660-669.
66. [66] Weinberger, D.R., Schizophrenia and the frontal lobe, Trends Nuerosci., 11 (1988) 367-370.
67. [67] Weiner, I., Neural substrates of latent inhibition: the switching model, Psychol. Bull., 108 (1990) 442-461.
68. [68] Weiner, I. and Feldon, J., Facilitation of latent inhibition by haloperidol, Psychopharmacology, 91 (1987) 248-253.
69. [69] Weiner, I., Feldon, J. and Katz, Y., Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats, Pharmacol. Biochem. Behav., 26 (1987) 241-246.
70. [70] Weiner, I., Izraeli-Telerant, A. and Feldon, J., Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine, Psychopharmacology, 91 (1987) 345-351.
71. [71] Weiner, I., Lubow, R.E. and Feldon, J., Chronic amphetamine and latent inhibition, Behav. Brain Res., 2 (1981) 285-286.
72. [72] Weiner, I., Lubow, R.E. and Feldon, J., Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats, Psychopharmacology, 83 (1984) 194-199.
73. [73] Weiner, I., Lubow, R.E. and Feldon, J., Disruption of latent inhibition by acute administration of low doses of amphetamine, Pharmacol. Biochem. Behav., 30 (1988) 871-878.
74. [74] Weiner, I., Tarrasch, R. and Feldon, J., Basolateral amygdala lesions do not disrupt latent inhibition (LI), Behav. Brain Res., in press.
75. [75] Wirtshafter, D., Asin, K.E. and Kent, K.W., Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity, Eur. J. Pharmacol., 51 (1978) 449-452.
76. [76] Witter, M.P., Groenewegen, H.J., Lopes da Silva, F.H. and Lohman, A.H.M., Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region, Prog. Neurobiol., 33 (1989) 162-253.
77. [77] Yee, B.K., Feldon, J. and Rawlins, J.N.P., Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region but this lesion effect can be prevented by systemic haloperidol treatment, Behav. Neurosci., 109 (1995) 227-240.
78. [78] Young, A.M.J., Joseph, M.H. and Gray, J.A., Latent inhibition of conditioned dopamine release in rat nucleus accumbens, Neuroscience, 54 (1993) 5-9.
79. [79] Zaborsky, L., Alheid, G.F., Beinfeld, M.C., Eiden, L.E., Heimer, L. and Palkovits, M., Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study, Neuroscience, 14 (1985) 427-453.
80. [80] Zahm, D.S. and Brog, J.S., On the significance of subterritories in the 'accumbens' part of the rat ventral striatum, Neuroscience, 50 (1992) 751-767.